For example, one previous study showed that the decreased shedding of AXL (and other RTKs) in cancer cells under the stress of Mitogen-activated protein kinase inhibitor (MEKi, U0126, and PD325901) resulted in cancer drug resistance [43]. This evidence concerns the gene WNK2 and cancer.